Water soluble membrane proteins and methods for the preparation and use thereof
AssigneeMassachusetts Institute of Technology
InventorsShuguang Zhang, Alexander Rich, Karolina Corin, Lotta T. Tegler
Life of this patent
Estimating the term…
Abstract
The present invention is directed to water-soluble membrane proteins, methods for the preparation thereof and methods of use thereof.
Claims76
A water-soluble polypeptide comprising a modified a-helical domain, wherein the modified α-helical domain comprises an amino acid sequence in which one or more hydrophobic amino acid residues within a α-helical domain of a native membrane protein is replaced with one or more hydrophilic amino acid residues.
(canceled)
(canceled)
A method of preparing a water-soluble polypeptide comprising replacing one or more hydrophobic amino acid residues within the α-helical domain of a native membrane protein with one or more hydrophilic amino acid residues.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method for treating a mammal suffering from a disorder or disease that is mediated by the activity of a native membrane protein, comprising administering to said mammal an effective amount of a water-soluble polypeptide comprising a modified α-helical domain, wherein the modified α-helical domain comprises an amino acid sequence in which one or more hydrophobic amino acid residues within a α-helical domain of the native membrane protein is replaced with one or more hydrophilic amino acid residues.
(canceled)
(cancelled)
(cancelled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method for producing a native ligand binding modified polypeptide of a transmembrane protein comprising the step of replacing or mutating at least some of the hydrophobic amino acid residues by hydrophilic amino acid residues wherein said modified polypeptide retains at least some of the ligand binding properties of said transmembrane protein.
A method for treating a disease or disorder mediated by ligand binding of a transmembrane protein comprising the step of administering a modified polypeptide wherein said polypeptide corresponds to a mutated amino acid sequence of said protein wherein transmembrane region of the sequence is modified so that at least some of the hydrophobic amino acid residues are replaced by hydrophilic amino acid residues.
75-89. (canceled)
Dependencies are inferred from the claim text.